VASHAWN MOSLEY: Open Payments
NPI 1679069231 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 82 payments from 10 companies in 2025. Trend: 2023 $2,170 · 2024 $1,444 · 2025 $2,028
Food & beverage: $2,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $321 |
| Neurocrine BioSciences, Inc. | 11 | $264 |
| Vanda Pharmaceuticals Inc. | 6 | $243 |
| Teva Pharmaceuticals USA, Inc. | 11 | $224 |
| Alkermes, Inc. | 8 | $212 |
| E.R. Squibb & Sons, L.L.C. | 12 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $192 |
| Otsuka America Pharmaceutical, Inc. | 6 | $170 |
| Axsome Therapeutics, Inc. | 3 | $132 |
| Lundbeck LLC | 3 | $66 |
Products named: VRAYLAR, INGREZZA, FANAPT, REXULTI, COBENFY, AUSTEDO XR, CAPLYTA, Auvelity.
Industry payments across FL — which companies pay providers there.
